Drug firm Sanofi India posted over two-fold increase in its net profit at Rs 92.7 crore for the fourth quarter ended December 31, 2013 on account of robust sales in export markets. The company had posted a net profit of Rs 44.8 crore during the same period of previous fiscal, Sanofi India said in a filing to the BSE. Net sales of the company rose to Rs 481.1 crore for the fourth quarter, as compared to Rs 400.7 crore during the same period of previous fiscal. The company follows a January-December financial year. For the year ended December 31, 2013, the company posted a net profit of Rs 265.2 crore, compared to Rs 176.7 crore in 2012. "Significantly better export performance during the quarter and year ended December 31, 2013 has resulted in improvement in profitability of the company," the company said. The company's board has recommended final dividend of Rs 35 per equity share of Rs 10 for the year ended December 31, 2013.
Wednesday, 26 February 2014
Sanofi India Q4 net surges two-fold at Rs 93 cr
Drug firm Sanofi India posted over two-fold increase in its net profit at Rs 92.7 crore for the fourth quarter ended December 31, 2013 on account of robust sales in export markets. The company had posted a net profit of Rs 44.8 crore during the same period of previous fiscal, Sanofi India said in a filing to the BSE. Net sales of the company rose to Rs 481.1 crore for the fourth quarter, as compared to Rs 400.7 crore during the same period of previous fiscal. The company follows a January-December financial year. For the year ended December 31, 2013, the company posted a net profit of Rs 265.2 crore, compared to Rs 176.7 crore in 2012. "Significantly better export performance during the quarter and year ended December 31, 2013 has resulted in improvement in profitability of the company," the company said. The company's board has recommended final dividend of Rs 35 per equity share of Rs 10 for the year ended December 31, 2013.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment